Macrogenics reported $26.01M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Amgen AMGN:US $ 6594M 356M
AstraZeneca AZN:LN 10771M 619M
Biogen BIIB:US $ 2589.1M 57.3M
Bristol Myers Squibb BMY:US $ 11887M 239M
Daiichi Sankyo 4568:JP Y 280317M 46392M
Eli Lilly And LLY:US $ 6488M 1322M
Epizyme EPZM:US $ 27.53M 18.83M
Genmab GEN:DC DK 3162M 1043M
Geron GERN:US $ 0.07M 0.05M
Gilead Sciences GILD:US $ 6260M 330M
Immunogen IMGN:US $ 14.16M 23.92M
Johnson & Johnson JNJ:US $ 24020M 594M
Karyopharm Therapeutics KPTI:US $ 39.68M 7.99M
Macrogenics MGNX:US $ 26.01M 14.91M
Merk MRK:US $ 14593M 1308M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Pfizer PFE:US $ 27742M 2081M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Xencor XNCR:US $ 30.18M 55.32M